Biostar Pharmaceuticals Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Biostar Pharmaceuticals's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 30 Sep 2017 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Biostar Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 17 | 0 | 1 | -4 | 1 |
| 30 Jun 17 | 1 | -1 | -2 | 1 |
| 31 Mar 17 | 2 | -6 | 3 | 1 |
| 31 Dec 16 | 2 | -6 | 3 | 1 |
| 30 Sep 16 | 4 | -32 | 17 | 1 |
| 30 Jun 16 | 7 | -32 | 17 | 2 |
| 31 Mar 16 | 21 | -26 | 16 | 3 |
| 31 Dec 15 | 27 | -25 | 18 | 4 |
| 30 Sep 15 | 40 | 1 | 16 | 4 |
| 30 Jun 15 | 50 | 2 | 20 | 3 |
| 31 Mar 15 | 55 | 4 | 22 | 3 |
| 31 Dec 14 | 61 | 5 | 26 | 3 |
| 30 Sep 14 | 58 | 3 | 26 | 3 |
| 30 Jun 14 | 58 | 3 | 25 | 3 |
| 31 Mar 14 | 54 | 1 | 24 | 3 |
| 31 Dec 13 | 53 | 1 | 22 | 3 |
Quality Earnings: Insufficient data to determine if BSPM has high quality earnings.
Growing Profit Margin: Insufficient data to determine if BSPM's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if BSPM's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare BSPM's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if BSPM's earnings growth over the past year exceeded the Pharmaceuticals industry average.
Return on Equity
High ROE: BSPM has a negative Return on Equity (0%), as it is currently unprofitable.